# D-serine Monotherapy for Schizophrenia

> **NCT00816894** · PHASE2 · COMPLETED · sponsor: **Herzog Hospital** · enrollment: 18 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** D-serine
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00816894
- **Lead sponsor:** Herzog Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816894, "D-serine Monotherapy for Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00816894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*